Torii Pharmaceutical Co., Ltd.
TSE:4551.T
4140 (JPY) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 54,638 | 48,894 | 46,987 | 41,699 | 42,997 | 62,550 | 64,134 | 60,206 | 62,377 | 43,502 | 58,108 | 52,292 | 48,716 | 45,335 | 42,416 | 37,348 | 40,844 | 39,576 | 40,483 | 41,914 |
Cost of Revenue
| 30,065 | 25,516 | 22,648 | 19,961 | 20,702 | 31,844 | 31,293 | 30,286 | 30,813 | 20,586 | 26,266 | 22,840 | 20,538 | 18,602 | 15,984 | 13,648 | 16,250 | 15,374 | 14,901 | 15,608 |
Gross Profit
| 24,573 | 23,378 | 24,339 | 21,738 | 22,295 | 30,706 | 32,841 | 29,920 | 31,564 | 22,916 | 31,842 | 29,452 | 28,178 | 26,733 | 26,432 | 23,700 | 24,594 | 24,202 | 25,582 | 26,306 |
Gross Profit Ratio
| 0.45 | 0.478 | 0.518 | 0.521 | 0.519 | 0.491 | 0.512 | 0.497 | 0.506 | 0.527 | 0.548 | 0.563 | 0.578 | 0.59 | 0.623 | 0.635 | 0.602 | 0.612 | 0.632 | 0.628 |
Reseach & Development Expenses
| 3,490 | 1,661 | 832 | 596 | 2,956 | 4,138 | 4,608 | 4,654 | 5,237 | 3,400 | 6,662 | 7,824 | 4,631 | 5,994 | 1,613 | 1,191 | 1,828 | 1,765 | 911 | 454 |
General & Administrative Expenses
| 2,033 | 1,707 | 0 | 0 | 0 | 0 | 581 | 564 | 570 | 585 | 1,131 | 2,333 | 2,383 | 3,339 | 3,321 | 2,331 | 2,294 | 5,745 | 5,903 | 5,870 |
Selling & Marketing Expenses
| 1,582 | 1,581 | 4,187 | 3,316 | 2,833 | 5,174 | 5,091 | 5,003 | 5,147 | 3,622 | 4,042 | 3,763 | 4,179 | 3,781 | 3,684 | 3,312 | 3,660 | 0 | 0 | 0 |
SG&A
| 16,047 | 1,581 | 4,187 | 3,316 | 2,833 | 5,174 | 5,091 | 5,003 | 5,147 | 3,622 | 4,042 | 6,096 | 6,562 | 7,120 | 7,005 | 5,643 | 5,954 | 5,745 | 5,903 | 5,870 |
Other Expenses
| 20 | 14,593 | 14,660 | 13,083 | 15,072 | 24 | 58 | 72 | 49 | 37 | 32 | 37 | 39 | 55 | 44 | 56 | 75 | 110 | -18 | 2,582 |
Operating Expenses
| 19,537 | 17,835 | 19,679 | 16,995 | 20,861 | 25,752 | 26,556 | 26,097 | 26,642 | 18,882 | 26,851 | 26,653 | 24,019 | 20,803 | 16,306 | 15,049 | 15,899 | 15,495 | 14,773 | 14,468 |
Operating Income
| 5,036 | 5,540 | 4,656 | 4,738 | 1,430 | 4,951 | 6,281 | 3,819 | 4,919 | 4,032 | 4,987 | 2,794 | 4,153 | 1,844 | 6,125 | 4,899 | 5,139 | 12,235 | 7,606 | 8,499 |
Operating Income Ratio
| 0.092 | 0.113 | 0.099 | 0.114 | 0.033 | 0.079 | 0.098 | 0.063 | 0.079 | 0.093 | 0.086 | 0.053 | 0.085 | 0.041 | 0.144 | 0.131 | 0.126 | 0.309 | 0.188 | 0.203 |
Total Other Income Expenses Net
| 557 | 182 | 111 | -513 | 36,270 | -1,921 | 92 | 237 | 339 | -251 | 146 | 135 | 901 | -4,260 | -4,031 | -2,971 | -6,989 | -6,801 | -6,579 | -4,335 |
Income Before Tax
| 5,593 | 5,722 | 4,767 | 4,225 | 37,700 | 3,030 | 6,373 | 4,056 | 5,258 | 3,781 | 5,133 | 2,929 | 5,054 | 1,839 | 6,340 | 6,038 | 5,378 | 5,434 | 7,537 | 10,115 |
Income Before Tax Ratio
| 0.102 | 0.117 | 0.101 | 0.101 | 0.877 | 0.048 | 0.099 | 0.067 | 0.084 | 0.087 | 0.088 | 0.056 | 0.104 | 0.041 | 0.149 | 0.162 | 0.132 | 0.137 | 0.186 | 0.241 |
Income Tax Expense
| 1,473 | 1,778 | 1,392 | 729 | 10,333 | 1,865 | 1,655 | 1,216 | 1,730 | 1,361 | 1,781 | 1,079 | 2,443 | 901 | 2,698 | 2,561 | 2,411 | 2,406 | 3,357 | 4,320 |
Net Income
| 4,119 | 3,944 | 3,374 | 3,495 | 27,367 | 1,164 | 4,718 | 2,839 | 3,527 | 2,419 | 3,352 | 1,849 | 2,611 | 937 | 3,642 | 3,476 | 2,967 | 3,028 | 4,179 | 5,793 |
Net Income Ratio
| 0.075 | 0.081 | 0.072 | 0.084 | 0.636 | 0.019 | 0.074 | 0.047 | 0.057 | 0.056 | 0.058 | 0.035 | 0.054 | 0.021 | 0.086 | 0.093 | 0.073 | 0.077 | 0.103 | 0.138 |
EPS
| 146.57 | 140.38 | 120.11 | 124.47 | 974.99 | 41.49 | 168.22 | 100.41 | 124.65 | 85.5 | 118.47 | 65.36 | 92.27 | 33.11 | 128.69 | 122.84 | 104.83 | 106.99 | 146.76 | 203.83 |
EPS Diluted
| 146.57 | 140.38 | 120.11 | 124.46 | 974.99 | 41.49 | 168.22 | 100.41 | 124.65 | 85.5 | 118.47 | 65.36 | 92.27 | 33.11 | 128.69 | 122.84 | 104.83 | 106.99 | 146.76 | 203.83 |
EBITDA
| 5,271 | 6,053 | 5,318 | 5,593 | 2,676 | 6,118 | 7,577 | 5,338 | 6,591 | 5,066 | 6,213 | 4,012 | 5,533 | 7,493 | 11,780 | 10,426 | 13,587 | 13,368 | 15,122 | 15,408 |
EBITDA Ratio
| 0.096 | 0.124 | 0.113 | 0.134 | 0.062 | 0.098 | 0.118 | 0.089 | 0.106 | 0.116 | 0.107 | 0.077 | 0.114 | 0.165 | 0.278 | 0.279 | 0.333 | 0.338 | 0.374 | 0.368 |